v3.25.2
Revenue
12 Months Ended
May 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue

Note 6 -- Revenue

 

Most of the Company’s revenue is generated by the performance of services to customers and recognized at a point in time based on the evaluation of when the customer obtains control of the products. Revenue is recognized when all performance obligations under the terms of a contract are satisfied, net of certain taxes. Revenue is recorded when customer acceptance is received and all performance obligations have been satisfied. Sales of goods typically do not include multiple products and/or service elements.

 

The table below summarizes the Company’s disaggregated revenue information:

        
   Year Ended May 31, 
   2025   2024 
Clinical trials  $301,731   $213,865 
Consulting fees       28,641 
Seminar fees       1,925 
Merchandise   1,291    4,410 
Total revenue  $303,022   $248,841 

 

Cost of revenue consists of third-party costs associated with the patient stipend and audio/video fees. At May 31, 2025, and May 31, 2024, cost of revenue totaled $40,106 and $45,599, respectively.